Boston-based private equity investor Advent International announced it signed a definitive agreement to acquire Ohio-based PatientPoint, which makes engagement platforms and apps for providers and patients, from an investor group led by L Catterton and Littlejohn & Co.
PatientPoint offers providers health content using digital screens in the clinic. It also works with life sciences companies to provide advertising slots on check-in and patient portals, on screens in waiting rooms, in healthcare staff waiting rooms and more.
The patient engagement company says it has a nationwide network of 30,000 physician offices and 125,000 providers.
PatientPoint's existing management team will continue leading the company with support from Advent advisors. The transaction is expected to close in Q4 2025, subject to regulatory approval and closing conditions.
"We're excited to help the company provide increasingly targeted messaging about treatment options and advanced therapies, offering sponsors and partners more efficient, personalized, and measurable campaigns," Chris Comenos, director at Advent, said in a statement.
"Given the platform's position in a patient's healthcare journey, we also believe it has strong potential to deliver new, innovative solutions that will drive beneficial health outcomes over time."
THE LARGER TREND
Last year, the company announced a partnership with MyHealthTeam, a social network company, to provide patients in more than 35,000 PatientPoint locations with a chance to connect with other individuals who have the same chronic health problems.
In 2021, PatientPoint merged with Outcome Health, creating the platform PatientPoint Health Technologies, aimed at facilitating patient-clinician communications.
PatientPoint joined forces with the American Medical Association in 2019 to help in the management of type 2 diabetes and cardiovascular disease.
The tech companies teamed up to disseminate AMA-developed chronic disease education and engagement content via PatientPoint's digital platform.
In 2017, the company secured $140 million in funding from Searchlight Capital Partners and Silver Point Capital to scale its point-of-care networks.
